Rua Bioscience Limited (NZE:RUA)
New Zealand · Delayed Price · Currency is NZD 0.0330
0.00 (0.00%)
At close: Mar 13, 2026
Rua Bioscience Revenue
Rua Bioscience had revenue of 1.46M NZD in the half year ending December 31, 2025, with 929.17% growth. This brings the company's revenue in the last twelve months to 2.39M, up 124.84% year-over-year. In the fiscal year ending June 30, 2025, Rua Bioscience had annual revenue of 1.83M with 477.39% growth.
Revenue (ttm)
2.39M
Revenue Growth
+124.84%
P/S Ratio
4.66
Revenue / Employee
n/a
Employees
n/a
Market Cap
11.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.83M | 1.51M | 477.39% |
| Jun 30, 2024 | 316.35K | -352.13K | -52.68% |
| Jun 30, 2023 | 668.48K | 23.39K | 3.63% |
| Jun 30, 2022 | 645.10K | 285.76K | 79.52% |
| Jun 30, 2021 | 359.34K | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EBOS Group | 15.12B |
| Fisher & Paykel Healthcare Corporation | 2.16B |
| Ryman Healthcare | 807.48M |
| Green Cross Health | 528.32M |
| Summerset Group Holdings | 360.86M |
| Radius Residential Care | 192.26M |
| Promisia Healthcare | 37.18M |
| Third Age Health Services | 20.32M |